Model
Edge
Theseus Pharmaceuticals Inc.
THRX
Filing type
8-K
Filing date
Feb 13, 2024
Updated
Feb 14, 2024 ยท 3:44 AM
Copy reference
Filing
8-K
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events
Exhibits
EX-3.1
EXHIBIT 3.1
EX-3.2
EXHIBIT 3.2